文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

重症监护病房中呼吸困难评估、管理与影响:快速综述与叙述性综合

Breathlessness assessment, management and impact in the intensive care unit: a rapid review and narrative synthesis.
PubMed 文献 · Ann Intensive Care · 2024-07-05
一句话结论ICU接受无创通气患者中55%在启动前自报中重度呼吸困难,接受有创通气者加权平均患病率49%,但ICU无呼吸困难管理指南。

该快速综述与叙述性综合遵循Cochrane方法学组建议并按PRISMA报告,检索2013年6月至2023年6月PubMed、MEDLINE、Cochrane Library和CINAHL,纳入19项研究共2822例ICU患者。接受有创机械通气患者呼吸困难加权平均患病率为49%(范围34-66%);接受无创通气患者在启动前自报中重度呼吸困难的比例为55%。评估工具包括视觉模拟量表(VAS)、数字评定量表(NRS)和改良BORG量表(mBORG)。作者结论认为,ICU中接受有创通气、无创通气或高流量氧疗的成人呼吸困难普遍且具有临床重要性,中位强度评分提示存在中重度症状。

要点

  • 接受有创机械通气的ICU患者呼吸困难加权平均患病率为49%(范围34-66%)。
  • 接受无创通气的患者中55%在启动前自报中重度呼吸困难。
  • 接受无创通气者最高报告的中位VAS、NRS和mBORG评分分别为6.2cm(0-10cm)、5(2-7)和6(2.3-7),提示中重度呼吸困难。
  • 接受无创通气或高流量氧疗者最高报告的中位VAS、NRS和mBORG评分分别为3cm(0-6cm)、8(5-10)和4(3-5)。
  • 呼吸困难评估工具包括视觉模拟量表(VAS)、数字评定量表(NRS)和改良BORG量表(mBORG)。

适用人群与场景

  • ICU中接受有创机械通气(IMV)、无创通气(NIV)或高流量氧疗(HFOT)的成人危重症患者。

研究设计与关键结果

  • 研究类型:快速综述与叙述性综合,遵循Cochrane方法学组建议并按PRISMA报告;检索PubMed、MEDLINE、Cochrane Library和CINAHL,检索时间2013年6月至2023年6月。
  • 纳入19项研究,共2822例ICU患者;参与者平均年龄48岁至71岁;男性比例43-100%。
  • 接受IMV的ICU患者呼吸困难加权平均患病率为49%(范围34-66%)。
  • 接受NIV的患者中,启动前自报中重度呼吸困难的比例为55%。
  • 接受NIV者最高报告的中位(四分位距[IQR])VAS、NRS和mBORG评分分别为6.2cm(0-10cm)、5(2-7)和6(2.3-7),提示中重度呼吸困难。
  • 接受NIV或HFOT者最高报告的中位(IQR)VAS、NRS和mBORG评分分别为3cm(0-6cm)、8(5-10)和4(3-5)。

证据类型、等级与局限

  • 证据类型:快速综述与叙述性综合;研究进行了质量评价。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,ICU中接受IMV、NIV或HFOT的成人呼吸困难普遍且具有临床重要性,中位强度评分提示存在中重度症状。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Adults in the intensive care unit (ICU) commonly experience distressing symptoms and other concerns such as pain, delirium, and breathlessness. Breathlessness management is not supported by any ICU guidelines, unlike other symptoms.

AIM: To review the literature relating to (i) prevalence, intensity, assessment, and management of breathlessness in critically ill adults in the ICU receiving invasive and non-invasive mechanical ventilation (NIV) and high-flow oxygen therapy, (HFOT), (ii) the impact of breathlessness on ICU patients with regard to engagement with rehabilitation.

METHODS: A rapid review and narrative synthesis using the Cochrane Methods Group Recommendations was conducted and reported in accordance with PRISMA. All study designs investigating breathlessness in adult ICU patients receiving either invasive mechanical ventilation (IMV), NIV or HFOT were eligible. PubMed, MEDLINE, The Cochrane Library and CINAHL databased were searched from June 2013 to June 2023. Studies were quality appraised.

RESULTS: 19 studies representing 2822 ICU patients were included (participants mean age 48 years to 71 years; proportion of males 43-100%). The weighted mean prevalence of breathlessness in ICU patients receiving IMV was 49% (range 34-66%). The proportion of patients receiving NIV self-reporting moderate to severe dyspnoea was 55% prior to initiation. Breathlessness assessment tools included visual analogue scale, (VAS), numerical rating scale, (NRS) and modified BORG scale, (mBORG). In patients receiving NIV the highest reported median (interquartile range [IQR]) VAS, NRS and mBORG scores were 6.2cm (0-10 cm), 5 (2-7) and 6 (2.3-7) respectively (moderate to severe breathlessness). In patients receiving either NIV or HFOT the highest reported median (IQR) VAS, NRS and mBORG scores were 3 cm (0-6 cm), 8 (5-10) and 4 (3-5) respectively.

CONCLUSION: Breathlessness in adults receiving IMV, NIV or HFOT in the ICU is prevalent and clinically important with median intensity ratings indicating the presence of moderate to severe symptoms.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Richardson BR, Decavèle M, Demoule A, et al. Breathlessness assessment, management and impact in the intensive care unit: a rapid review and narrative synthesis. Ann Intensive Care. 2024. PMID: 38967813. doi:10.1186/s13613-024-01338-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。